ProFibrix's Series B Round

ProFibrix raised a round of funding on August 05, 2009.

ProFibrix leverages its expertise in fibrinogen technology to develop and market products for the hemostasis and regenerative medicine markets. Human fibrinogen plays a pivotal role in blood clotting …

Articles about ProFibrix's Series B Round: